SCHEMBL21518244

SCHEMBL21518244

COC(=O)CC1OC(OC)C(NC(C)=O)C(OC(C)=O)C1OC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.48
▸ POLB P06746 2/20 0.48
▸ MMP9 P14780 2/20 0.46
▸ MMP12 P39900 2/20 0.46
▸ CYP3A4 P08684 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ LGALS8 O00214 2/20 0.39
▸ CYP2D6 P10635 2/20 0.36
▸ THRB P10828 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ LGALS3 P17931 4/20 0.34
▸ LGALS1 P09382 1/20 0.34
▸ LGALS7; LGALS7B P47929 1/20 0.34
▸ BCHE P06276 1/20 0.33
▸ LGALS9 O00182 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21518246 0.93 LMNA (0.53) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL24645816 0.86 LMNA (0.48) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL24699769 0.86 LMNA (0.48) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL17230163 0.85 LMNA (0.53) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL19772702 0.84 LMNA (0.64) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL24807806 0.84 LMNA (0.64) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL22927913 0.84 LMNA (0.64) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL18513238 0.84 LMNA (0.64) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL15334243 0.84 LMNA (0.64) LMNAKMT2AALDH1A1POLBMMP9
SCHEMBL18972833 0.84 LMNA (0.64) LMNAKMT2AALDH1A1POLBMMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558323-A1 SPECIFIC TLR4 ANTAGONIST IN THE TREATMENT OF MULTIPLE MYELOMA Etablissement Français du Sang (FR) 2019-10-30 — — EP disclosed
Send feedback